Hyperthyroidism Explained: What an Overactive Thyroid Does to Your Body and How It’s Treated

Hyperthyroidism is the opposite problem from hypothyroidism – instead of too little thyroid hormone, there’s too much. And while the symptoms sound like they might be harmless or even desirable (weight loss, lots of energy, fast metabolism), the reality is very different. An overactive thyroid puts chronic stress on the heart, depletes bone density, disrupts the nervous system, and – if left untreated – can trigger life-threatening complications.

Roughly 1 in 100 Americans has hyperthyroidism. It’s significantly more common in women and can develop at almost any age, though Graves’ disease – the most common cause – tends to peak in women in their 20s-40s.

---

What Happens When Too Much Thyroid Hormone Circulates

Thyroid hormone – particularly T3, the active form – sets the metabolic rate of virtually every cell in the body. In hyperthyroidism, this dial is turned up too high. Cells burn energy faster, the nervous system becomes hyperactivated, and organs that are particularly sensitive to thyroid hormone – especially the heart – are pushed beyond their optimal operating conditions.

The body’s feedback system responds: when the pituitary detects excess thyroid hormone in circulation, it cuts TSH production to near zero, trying to stop the thyroid from producing more. This is why TSH is the first test to fall in hyperthyroidism – it often becomes undetectable even before T4 has risen dramatically above normal.

---

Causes: Why the Thyroid Overproduces

Graves’ Disease – The Most Common Cause

Graves’ disease accounts for approximately 70-80% of hyperthyroidism cases and is the most common autoimmune thyroid condition causing hormone excess.

In Graves’ disease, the immune system produces antibodies called thyroid-stimulating immunoglobulins (TSI) – also called TSH receptor antibodies (TRAb) – that bind to and continuously activate the TSH receptor on thyroid cells. Unlike TSH itself (which responds to feedback signals and turns off when hormone levels are adequate), these antibodies don’t shut off. They stimulate the thyroid to produce hormone constantly, independent of the body’s actual needs.

The result is a continuously overdriven thyroid that the pituitary has no mechanism to suppress.

Graves’ disease has two distinctive features beyond thyroid overactivity:

Graves’ ophthalmopathy (thyroid eye disease): Present in approximately 25-30% of Graves’ patients, this involves immune-mediated inflammation and expansion of the fat and muscle tissue behind the eyes, causing:

• Exophthalmos (proptosis) – bulging or protrusion of the eyes
• Eyelid retraction – a wide-eyed stare
• Periorbital swelling and redness
• Double vision (diplopia) from extraocular muscle involvement
• Dry, gritty eyes or excessive tearing
• In severe cases: vision loss from optic nerve compression

Crucially, the eye disease follows a different course from the thyroid disease. Graves’ ophthalmopathy can worsen even after the thyroid is treated, and radioactive iodine therapy may temporarily worsen eye disease – an important consideration in treatment planning. Severe eye disease requires specialist ophthalmology involvement.

Pretibial myxedema (dermopathy): A less common manifestation – thickened, lumpy skin most often over the shins, from glycosaminoglycan deposition. Despite the name, it occurs in the context of hyperthyroidism, not hypothyroidism.

Toxic Multinodular Goiter

In older adults, the second most common cause of hyperthyroidism is toxic multinodular goiter – where multiple nodules within the thyroid develop autonomous function, producing hormone independently of TSH signaling. The hyperthyroidism typically develops slowly and may be subtle, often presenting with atrial fibrillation or unexplained weight loss in an older patient. Radioactive iodine or surgery are the preferred treatments for this cause.

Toxic Adenoma

A single autonomously functioning nodule (toxic adenoma) can produce enough hormone to suppress TSH and cause hyperthyroidism. These are usually identifiable on thyroid scan as a “hot nodule” – one that takes up significantly more radioactive iodine than the surrounding suppressed tissue. Treatment with RAI or surgery is typically definitive.

Thyroiditis

Various forms of thyroid inflammation cause temporary hormone release from damaged follicles – producing a transient hyperthyroid phase that typically lasts weeks to a few months before resolving (sometimes followed by a transient hypothyroid phase as the gland recovers):

• Subacute granulomatous thyroiditis (de Quervain’s): Often preceded by a viral illness, presents with neck pain and tenderness, elevated CRP, and transient hyperthyroidism
• Silent (painless) thyroiditis: No neck pain; may occur postpartum or spontaneously
• Postpartum thyroiditis: Affects 5-10% of women in the year after delivery; hyperthyroid phase typically at 1-4 months postpartum
• Drug-induced thyroiditis: Amiodarone, interferon, lithium, and immune checkpoint inhibitor cancer therapies can all trigger thyroid inflammation

Thyroiditis-related hyperthyroidism is transient and treated symptomatically (beta-blockers, anti-inflammatory agents) rather than with antithyroid drugs or RAI, because the hormone release is from existing stores rather than ongoing synthesis.

Iodine-Induced Hyperthyroidism (Jod-Basedow)

Exposure to large amounts of iodine (from amiodarone, iodinated contrast dye used in CT scans, or excess iodine supplements) can trigger hyperthyroidism in people with underlying autonomous thyroid tissue – typically older adults with multinodular goiter. This is why iodine-containing supplements and contrast media require thoughtful use in people with known thyroid disease.

---

Symptoms: The Body Running Too Fast

The symptoms of hyperthyroidism reflect a body with its metabolic rate abnormally elevated across multiple systems:

Cardiovascular:

• Palpitations – awareness of a rapid, forceful, or irregular heartbeat
• Resting tachycardia (heart rate persistently over 90-100 bpm)
• Atrial fibrillation – in about 10-15% of patients, particularly older adults; an important complication that increases stroke risk and may be the presenting finding in elderly patients who lack the classic hypermetabolic symptoms
• Hypertension (systolic predominantly)
• Heart failure in severe prolonged disease

Metabolic/weight:

• Weight loss despite increased or normal appetite – the body is burning fuel faster than it can be consumed
• Increased appetite (polyphagia) in some patients
• Heat intolerance – feeling hot when others are comfortable
• Excessive sweating

Neurological/psychiatric:

• Anxiety, nervousness, irritability, emotional lability
• Tremor – fine, rapid tremor most apparent in the outstretched hands
• Difficulty concentrating, restlessness
• Insomnia
• Fatigue despite feeling “wired”

Musculoskeletal:

• Proximal muscle weakness – difficulty climbing stairs, rising from a chair, lifting arms overhead
• In severe or prolonged hyperthyroidism: thyrotoxic myopathy
• Accelerated bone resorption leading to osteoporosis with prolonged untreated disease

Gastrointestinal:

• Frequent bowel movements or diarrhea
• Nausea in some cases

Reproductive:

• Menstrual irregularities (often oligomenorrhea – infrequent periods)
• Reduced fertility

Physical signs:

• Goiter (enlarged thyroid) – most prominent in Graves’ disease and toxic multinodular goiter
• Warm, moist, smooth skin
• Fine, soft hair
• Stare (eyelid retraction from sympathetic stimulation – distinct from Graves’ ophthalmopathy)
• In Graves’ specifically: exophthalmos, pretibial myxedema, acropachy (clubbing-like changes)

In older adults, hyperthyroidism frequently presents atypically – without the classic hypermetabolic picture. Instead: unexplained weight loss, new atrial fibrillation, worsening heart failure, or apathy (“apathetic hyperthyroidism”) rather than anxiety. This “masked” presentation delays diagnosis.

---

Thyroid Storm: The Life-Threatening Emergency

Thyroid storm is an acute, severe exacerbation of hyperthyroidism – a medical emergency with mortality rates of 10-30% even with treatment. It’s typically precipitated in a patient with uncontrolled or incompletely treated hyperthyroidism by a physiological stressor: infection, surgery, trauma, childbirth, or cessation of antithyroid medications.

Features of thyroid storm include:

• Extreme hyperthermia (fever above 38.5-40°C / 101-104°F)
• Severe tachycardia, often with arrhythmia
• Agitation, confusion, psychosis, or coma
• Severe hypertension or cardiovascular compromise
• Nausea, vomiting, diarrhea
• Jaundice in severe cases

The Burch-Wartofsky Point Scale is used to assess the likelihood of thyroid storm. Suspected thyroid storm requires immediate emergency department evaluation and treatment with propylthiouracil (PTU) or methimazole, iodine, beta-blockers, corticosteroids, and supportive care.

---

Diagnosis

TSH is usually the first test – in primary hyperthyroidism, TSH is suppressed (below 0.4 mIU/L, often below 0.1 or undetectable). Free T4 and Free T3 confirm and quantify the excess.

Pattern recognition:

• Low TSH + high Free T4: Overt hyperthyroidism
• Low TSH + normal Free T4 and T3: Subclinical hyperthyroidism
• Low TSH + high T3 but normal T4: T3 toxicosis (particularly common with toxic adenoma and early Graves’)

Distinguishing the cause:

• TSI/TRAb antibodies: Positive in Graves’ disease; the most specific confirmatory test
• Thyroid uptake scan: Measures how much radioactive iodine the thyroid takes up; helps distinguish Graves’ (diffusely elevated uptake) from thyroiditis (very low uptake – damaged tissue releases hormone but can’t take up iodine) from toxic nodule (focal “hot” area)
• Thyroid ultrasound with Doppler: Increased blood flow (“thyroid inferno”) supports Graves’; useful for nodule evaluation

---

Treatment Options

Three main options exist for hyperthyroidism, each with distinct advantages and considerations:

Antithyroid Medications (ATDs)

Methimazole (Tapazole) and propylthiouracil (PTU) block thyroid hormone synthesis by inhibiting thyroid peroxidase, the enzyme required for iodination of thyroglobulin.

• Methimazole is preferred in most situations – longer half-life allows once-daily dosing, more potent, lower risk of serious side effects
• PTU is preferred in the first trimester of pregnancy (methimazole carries a small risk of specific birth defects) and in thyroid storm (also blocks T4-to-T3 conversion)
• Typically given for 12-18 months for Graves’ disease; remission (sustained normal thyroid function off medication) occurs in about 30-50% of Graves’ patients
• Serious side effects: Agranulocytosis (dangerous reduction in white blood cells, affecting about 0.3% of patients) and liver injury (rare but potentially severe with PTU). Patients should be warned to seek immediate care for fever, sore throat, or jaundice

Radioactive Iodine (RAI) Therapy

RAI (iodine-131) is taken orally. The thyroid concentrates iodine, so the radioactivity preferentially destroys thyroid tissue while minimizing systemic radiation exposure. It’s the most common definitive treatment for Graves’ disease and toxic nodular disease in the US.

• Very effective – most patients become hypothyroid within 6-12 months and require lifelong levothyroxine
• Contraindicated in pregnancy and breastfeeding; women should avoid pregnancy for 6 months after treatment
• May worsen active Graves’ ophthalmopathy – pretreatment with corticosteroids is recommended in patients with moderate-to-severe eye disease

Thyroidectomy

Surgical removal of the thyroid is appropriate when: rapid normalization of thyroid function is needed, RAI is contraindicated or refused, there’s suspicion of malignancy, there’s a large goiter causing compressive symptoms, or active Graves’ ophthalmopathy makes RAI less desirable.

Risks include hypoparathyroidism (damage to parathyroid glands), recurrent laryngeal nerve injury causing voice changes, and postoperative hypothyroidism requiring lifelong levothyroxine.

Beta-Blockers: Symptom Control, Not Thyroid Treatment

Beta-blockers (propranolol, atenolol) don’t treat hyperthyroidism itself but rapidly control many of its most distressing symptoms – palpitations, tremor, anxiety, and excessive sweating. They’re routinely used while awaiting the effects of ATDs or RAI.

---

Frequently Asked Questions

Can Graves’ disease go into remission on its own? Spontaneous remission of Graves’ disease does occur, but it’s unpredictable. After a 12-18 month course of antithyroid medication, approximately 30-50% of patients achieve remission and can come off treatment. Predictors of remission include small goiter, mild hyperthyroidism, and TRAb antibody levels that decline with treatment. The other 50-70% relapse and typically require definitive therapy with RAI or surgery.

Will I need to take medication forever after RAI or thyroid surgery? Almost certainly yes. RAI and total thyroidectomy result in permanent hypothyroidism requiring lifelong levothyroxine. Even partial thyroidectomy often results in eventual hypothyroidism. This is the trade-off of definitive therapy – curing hyperthyroidism at the cost of converting to a managed hypothyroid state.

Is hyperthyroidism dangerous for the heart? Yes – particularly in older adults and those with pre-existing heart disease. The most significant cardiac risks are atrial fibrillation (present in 10-15% of hyperthyroid patients), which requires anticoagulation and increases stroke risk, and high-output heart failure from the chronically elevated cardiac demands. Persistent tachycardia itself (tachycardia-mediated cardiomyopathy) can impair heart function if untreated long enough.

I’m pregnant and have Graves’ disease. Is it safe? Graves’ disease in pregnancy requires careful management. Uncontrolled hyperthyroidism is associated with miscarriage, preterm birth, preeclampsia, and low birth weight. PTU is preferred in the first trimester; methimazole can be used in the second and third trimesters. Maternal TRAb antibodies can cross the placenta and cause neonatal hyperthyroidism in the baby – fetal monitoring is important when maternal TRAb levels are elevated. Management should be with an endocrinologist with expertise in thyroid disease in pregnancy.

Can hyperthyroidism cause bone loss? Yes. Excess thyroid hormone accelerates bone resorption and can cause or worsen osteoporosis, particularly in postmenopausal women. This is another reason to treat hyperthyroidism promptly – the bone loss from years of uncontrolled disease may not fully reverse even after treatment. Bone density testing (DEXA scan) may be appropriate after sustained hyperthyroidism.

---

Disclaimer

This article is for educational purposes only and does not constitute medical advice. Hyperthyroidism diagnosis and management should be directed by a qualified healthcare provider. If you are experiencing symptoms of thyroid storm – extreme fever, rapid heart rate, confusion – call 911 immediately.

---

References

1. Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association guidelines for hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016;26(10):1343-1421. https://doi.org/10.1089/thy.2016.0229
2. Smith TJ, Hegedüs L. Graves’ disease. New England Journal of Medicine. 2016;375(16):1552-1565. https://doi.org/10.1056/NEJMra1510030
3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Hyperthyroidism. https://www.niddk.nih.gov/health-information/endocrine-diseases/hyperthyroidism
4. American Thyroid Association. Hyperthyroidism. https://www.thyroid.org/hyperthyroidism/
5. Burch HB, Cooper DS. Management of Graves’ disease: a review. JAMA. 2015;314(23):2544-2554. https://doi.org/10.1001/jama.2015.16535
6. Bartalena L, Baldeschi L, Boboridis K, et al. The 2016 European Thyroid Association/European Group on Graves’ Orbitopathy guidelines for the management of Graves’ orbitopathy. European Thyroid Journal. 2016;5(1):9-26. https://doi.org/10.1159/000443828
7. Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the ATA and AACE. Thyroid. 2011;21(6):593-646. https://doi.org/10.1089/thy.2010.0417
8. MedlinePlus – National Library of Medicine. Hyperthyroidism. https://medlineplus.gov/hyperthyroidism.html
9. Kravets I. Hyperthyroidism: diagnosis and treatment. American Family Physician. 2016;93(5):363-370. https://www.aafp.org/pubs/afp/issues/2016/0301/p363.html
10. Abraham P, Avenell A, McGeoch SC, Clark LF, Bevan JS. Antithyroid drug regimen for treating Graves’ hyperthyroidism. Cochrane Database of Systematic Reviews. 2010;(1):CD003420. https://doi.org/10.1002/14651858.CD003420.pub4